IRIS

Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia

BERTAINA, ALICE;LOCATELLI, FRANCO;
2014-01-01
2014
CELL CYCLE
WOS:000340272100015
2-s2.0-84904404354
Inglese
13
14
2237
2247
11
24874015
Apoptosis; Aurora kinases; Caspases; Cell cycle; MEK/ERK/mTORC1; PI3K/Akt/mTORC2; Polo-like kinases; T-ALL; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aza Compounds; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Coculture Techniques; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Indoles; Jurkat Cells; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein-Serine-Threonine Kinases; Proto-Oncogene Proteins; Signal Transduction; Thiazoles; Tumor Cells, Cultured; Drug Design; Molecular Targeted Therapy; Cell Biology; Molecular Biology; Developmental Biology
https://www.landesbioscience.com/journals/cc/2014CC5788.pdf
13
info:eu-repo/semantics/article
262
Spartà, Antonino Maria; Bressanin, Daniela; Chiarini, Francesca; Lonetti, Annalisa; Cappellini, Alessandra; Evangelisti, Cecilia; Evangelisti, Camilla...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1112793
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 29
social impact